129 related articles for article (PubMed ID: 19838540)
1. Flunarizine and cinnarizine-induced parkinsonism: 25 years of de Melo-Souza's syndrome.
Teive HA; Munhoz RP; Ferraz HB
Arq Neuropsiquiatr; 2009 Sep; 67(3B):957. PubMed ID: 19838540
[No Abstract] [Full Text] [Related]
2. Iatrogenic parkinsonism: the role of flunarizine and cinnarizine.
Miguel R; Correia AS; Bugalho P
J Parkinsons Dis; 2014; 4(4):645-9. PubMed ID: 25125483
[TBL] [Abstract][Full Text] [Related]
3. Parkinsonism and other movement disorders in outpatients in chronic use of cinnarizine and flunarizine.
Fabiani G; Pastro PC; Froehner C
Arq Neuropsiquiatr; 2004 Sep; 62(3B):784-8. PubMed ID: 15476069
[TBL] [Abstract][Full Text] [Related]
4. Permanent non-progressive cinnarizine and flunarizine-induced parkinsonism: An under-recognized tardive syndrome in the elderly?
Calzetti S; Negrotti A
J Neurol Sci; 2023 Jan; 444():120526. PubMed ID: 36584558
[TBL] [Abstract][Full Text] [Related]
5. Flunarizine and cinnarizine-induced parkinsonism: a historical and clinical analysis.
Teive HA; Troiano AR; Germiniani FM; Werneck LC
Parkinsonism Relat Disord; 2004 Jun; 10(4):243-5. PubMed ID: 15120099
[TBL] [Abstract][Full Text] [Related]
6. A long-term follow-up study of cinnarizine- and flunarizine-induced parkinsonism.
Negrotti A; Calzetti S
Mov Disord; 1997 Jan; 12(1):107-10. PubMed ID: 8990063
[TBL] [Abstract][Full Text] [Related]
7. Risk of parkinsonism induced by flunarizine or cinnarizine: a population-based study.
Lin HL; Lin HC; Tseng YF; Chen SC; Hsu CY
Eur J Clin Pharmacol; 2017 Mar; 73(3):365-371. PubMed ID: 27986997
[TBL] [Abstract][Full Text] [Related]
8. Extrapyramidal symptoms after exposure to calcium channel blocker-flunarizine or cinnarizine.
Jhang KM; Huang JY; Nfor ON; Tung YC; Ku WY; Lee CT; Liaw YP
Eur J Clin Pharmacol; 2017 Jul; 73(7):911-916. PubMed ID: 28386684
[TBL] [Abstract][Full Text] [Related]
9. Calcium-entry blockers-induced parkinsonism: possible role of inherited susceptibility.
Negrotti A; Calzetti S; Sasso E
Neurotoxicology; 1992; 13(1):261-4. PubMed ID: 1508427
[TBL] [Abstract][Full Text] [Related]
10. Extrapyramidal symptoms associated with calcium-channel blockers.
Daniel JR; Mauro VF
Ann Pharmacother; 1995 Jan; 29(1):73-5. PubMed ID: 7711350
[TBL] [Abstract][Full Text] [Related]
11. Flunarizine- and cinnarizine-induced extrapyramidal reactions.
Micheli F; Pardal MF; Gatto M; Torres M; Paradiso G; Parera IC; Giannaula R
Neurology; 1987 May; 37(5):881-4. PubMed ID: 3574697
[TBL] [Abstract][Full Text] [Related]
12. Parkinsonism, tremor, and depression induced by cinnarizine and flunarizine.
Capellà D; Laporte JR; Castel JM; Tristán C; Cos A; Morales-Olivas FJ
BMJ; 1988 Sep; 297(6650):722-3. PubMed ID: 3147743
[No Abstract] [Full Text] [Related]
13. Effects of cinnarizine, a calcium antagonist that produces human parkinsonism, in parkin knock out mice.
Serrano A; Menéndez J; Casarejos MJ; Solano RM; Gallego E; Sánchez M; Mena MA; García de Yebenes J
Neuropharmacology; 2005 Aug; 49(2):208-19. PubMed ID: 15993444
[TBL] [Abstract][Full Text] [Related]
14. Movement disorders and depression due to flunarizine and cinnarizine.
Micheli FE; Pardal MM; Giannaula R; Gatto M; Parera I; Paradiso G; Torres M; Pikielny R; Pardal J
Mov Disord; 1989; 4(2):139-46. PubMed ID: 2733706
[TBL] [Abstract][Full Text] [Related]
15. D2 receptor blockade by flunarizine and cinnarizine explains extrapyramidal side effects. A SPECT study.
Brücke T; Wöber C; Podreka I; Wöber-Bingöl C; Asenbaum S; Aull S; Wenger S; Ilieva D; Harasko-van der Meer C; Wessely P
J Cereb Blood Flow Metab; 1995 May; 15(3):513-8. PubMed ID: 7714010
[TBL] [Abstract][Full Text] [Related]
16. Flunarizine, a calcium channel blocker: a new prophylactic drug in migraine.
Amery WK
Headache; 1983 Mar; 23(2):70-4. PubMed ID: 6343298
[No Abstract] [Full Text] [Related]
17. L-type calcium channel blockers and a symptom complex mimicking de Melo-Souza's syndrome.
Kaur U; Das P; Gambhir IS; Chakrabarti SS
Neurol Sci; 2019 May; 40(5):1077-1080. PubMed ID: 30506121
[No Abstract] [Full Text] [Related]
18. [Calcium antagonists in the urethral syndrome of women with urinary incontinence and urgency].
Granados Loarca EA
Actas Urol Esp; 2006 Apr; 30(4):406-8. PubMed ID: 16838613
[TBL] [Abstract][Full Text] [Related]
19. Useless drugs are not placebos: lessons from flunarizine and cinnarizine.
Laporte JR; Capella D
Lancet; 1986 Oct; 2(8511):853-4. PubMed ID: 2876292
[No Abstract] [Full Text] [Related]
20. Flunarizine-induced parkinsonism: clinical report.
Moretti A; Lucantoni C
Ital J Neurol Sci; 1988 Jun; 9(3):295-7. PubMed ID: 3403223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
